The 20 Best Familial Hyperaldosteronism Doctors Near Me in Ann Arbor, MI

Dr. Else’s primary appointment is with the Division of Metabolism, Endocrinology and Diabetes. He received his MD degree from the University of Hamburg, Germany. He pursued his clinical training at the University of Hamburg (Residency: Internal Medicine) and the University of Michigan (Residency: Internal Medicine, Fellowship: Endocrinology). His main research interests are the genetics of endocrine tumors. Dr. Else’s clinical practice focuses on the care for patients with benign and malignant endocrine tumors, particularly pheochromocytoma, adrenocortical tumors and neuroendocrine tumors as well as accompanying hormone excess syndromes (e.g Cushing syndrome, primary aldosteronism). Dr. Else has a particular interest in taking care of patients with hereditary syndromes that predispose to the development of endocrine tumors (e.g. Multiple Endocrine Neoplasia (MEN) type 1, MEN2A & MEN2B, Hereditary Paraganglioma Syndrome). He attends the Multidisciplinary Endocrine Oncology Clinic, where patients with tumors receive diagnostic procedures and treatment. In addition he is part of the Cancer Genetics Clinic, which evaluates patients for hereditary syndromes and also facilitates regular exams and surveillance for patients at risk for endocrine tumors. Dr. Else is rated as a Distinguished provider by MediFind in the treatment of Familial Hyperaldosteronism. His top areas of expertise are Adrenal Cancer, Adrenocortical Carcinoma, Adrenal Gland Adenoma, Neuroendocrine Tumor, and Thyroidectomy.

Dr. Richard Auchus is a professor of Internal Medicine, Division of Metabolism, Endocrinology & Diabetes (MEND) and Chief of the Endocrinology & Metabolism Section at the Ann Arbor VA Medical Center. He received his medical degree and Ph.D. in pharmacology from Washington University in St. Louis. Then Dr. Auchus completed a residency at the University of Iowa and an endocrinology fellowship at UTHSC-San Antonio/Wilford Hall Medical Center. Dr. Auchus came to UMHS from the Graduate School of Biomedical Sciences in Southwestern Medical School, University of Texas, where he was a Professor of Internal Medicine - Endocrinology.Dr. Auchus is a steroid biologist with expertise both in basic science and clinical/translational science. His work has included translational research into: molecular and genetic mechanisms of human hypertension, improved diagnostic studies and management in primary aldosteronism and Cushing syndromes, modifier genes in 21-hydroxylase deficiency, cardiovascular disease in polycystic ovary syndrome, and the endocrinology of traumatic brain injury. Dr. Auchus is rated as a Distinguished provider by MediFind in the treatment of Familial Hyperaldosteronism. His top areas of expertise are Congenital Adrenal Hyperplasia (CAH), Intersex, Cushing's syndrome, Hormone Replacement Therapy (HRT), and Orchiectomy.

Shafaq Khairi is an Internal Medicine specialist and an Endocrinologist in Ann Arbor, Michigan. Dr. Khairi is rated as a Distinguished provider by MediFind in the treatment of Familial Hyperaldosteronism. Her top areas of expertise are Hyperaldosteronism, Familial Hyperaldosteronism, Multiple Endocrine Neoplasia Type 1, and Hyperparathyroidism.

Dr. Adina Turcu completed her Internal Medicine residency at Norwalk Hospital/Yale University, CT, where she also served a year as Chief Resident. She completed her Endocrinology fellowship at Mayo Clinic, Rochester, MN, where she was the recipient of the Randall G. Sprague Award for outstanding clinical, investigative, and academic achievement in Endocrinology.Dr. Turcu pursued a postdoctoral fellowship at the University of Michigan, prior to joining the UoM faculty team in the Division of Metabolism, Endocrinology & Diabetes. Her research work focuses on adrenal disorders, including congenital adrenal hyperplasia, Cushing’s syndrome, primary aldosteronism, and pheochromocytoma/paraganglioma. Dr. Turcu is rated as a Distinguished provider by MediFind in the treatment of Familial Hyperaldosteronism. Her top areas of expertise are Hyperaldosteronism, Congenital Adrenal Hyperplasia (CAH), Adrenal Gland Adenoma, Ovarian Overproduction of Androgens, and Hormone Replacement Therapy (HRT).

Zahrae Sandouk M.D., is a Clinical Assistant Professor, board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism and a graduate from Henry Ford Hospital and Cleveland Clinic who has an interest in Diabetes mellitus, Diabetes complications, Cystic Fibrosis related Diabetes, Pituitary disorders, Prolactinoma, Hypopituitarism, Thyroid disorders, Bone and calcium disorders, Adrenal and Osteoporosis. Also the medical director of the Endocrine Testing Unity at the University of Michigan where dynamic studies are performed and is also part of the Cystic Fibrosis multidisciplinary team. Dr. Sandouk is rated as an Experienced provider by MediFind in the treatment of Familial Hyperaldosteronism. Her top areas of expertise are Type 1 Diabetes (T1D), Adrenal Insufficiency Pediatric, Type 2 Diabetes (T2D), and Thyroid Nodule.

Cristina Nieves is an Internal Medicine specialist and an Endocrinologist in Ann Arbor, Michigan. Dr. Nieves is rated as an Experienced provider by MediFind in the treatment of Familial Hyperaldosteronism. Her top areas of expertise are Toxic Nodular Goiter, Thyroid Storm, Type 2 Diabetes (T2D), and Low Blood Sugar.

Daniyeh Khurram is an Internal Medicine specialist and an Endocrinologist in Ann Arbor, Michigan. Dr. Khurram is rated as an Experienced provider by MediFind in the treatment of Familial Hyperaldosteronism. Her top areas of expertise are Hyperparathyroidism, Neonatal Severe Hyperparathyroidism, Osteitis Fibrosa, Thrombectomy, and Endoscopy.

Debbie Chen is an Internal Medicine specialist and an Endocrinologist in Ann Arbor, Michigan. Dr. Chen is rated as an Experienced provider by MediFind in the treatment of Familial Hyperaldosteronism. Her top areas of expertise are Thyroid Cancer, Follicular Thyroid Cancer, Papillary Thyroid Cancer, and Medullary Thyroid Carcinoma.

Dr. Elif Oral is a professor in the Division of Metabolism, Endocrinology and Diabetes (MEND) at the University of Michigan. She completed her medical education in her home country of Turkey at the University of Istanbul. In 1996, she completed her residency in Internal Medicine at Sinai Hospital Detroit (Michigan). She then completed a fellowship in Endocrinology, Metabolism and Diabetes at the National Institute of Health, where she also chose to stay as a Senior Fellow under the mentorship of Drs SimeonTaylor and Phillip Gorden in in the Diabetes Branch of NIDDK.Since joining the University of Michigan in 2002 as an Assistant Professor of Medicine, along with her regular faculty responsibilities, Dr. Oral also completed a Masters of Science Degree in Clinical Research Design and Biostatistics at the School of Public Health. Her clinical interests are in insulin resistance, obesity, lipid disorders, and diabetes.Dr Oral's research focuses on the importance of adipocytes in human metabolism and adipocyte hormones such as leptin. She is best known for her work showing the remarkable efficacy of leptin in rare lipodystrophy syndromes. Metreleptin received approval by the FDA (2014) and EMA (2016) as a treatment for lipodystrophy owing to a large part to her original vision and work. These studies provided the basis for her current work with three big goals: identification of novel metabolic diseases, discovery of new disease mechanisms and finding treatments for patients afflicted with these disorders. In addition to her roles as physician, educator, and researcher, Dr Oral is also the director of two programs at MEND: Atypical Diabetes Program and Obesity and Metabolic Disorders Program. She directed the Post-Bariatric Surgery Care Program from 2012 to 2021 and continues to conduct research on the cohort of patients who had bariatric surgery performed in the Michigan Bariatric Surgery program. Dr. Oral is rated as an Experienced provider by MediFind in the treatment of Familial Hyperaldosteronism. Her top areas of expertise are Familial Partial Lipodystrophy, Congenital Generalized Lipodystrophy, Familial Hypertriglyceridemia, Gastric Bypass, and Sleeve Gastrectomy.

Preethi Gogineni is an Internal Medicine specialist and an Endocrinologist in Ann Arbor, Michigan. Dr. Gogineni has been practicing medicine for over 10 years and is rated as an Experienced provider by MediFind in the treatment of Familial Hyperaldosteronism. Her top areas of expertise are Hyperparathyroidism, Type 1 Diabetes (T1D), Gestational Diabetes, and Osteoporosis.

Dr. Lynn Ang is currently a Clinical Associate Professor in the Metabolism, Endocrinology, and Diabetes Division, Internal Medicine Department at University of Michigan. Dr. Ang is one of the principle attending physicians for the Diabetes Transition Program. Dr. Ang’s clinical and research interests are in the fields of implementing optimal management of inpatient and outpatient hyperglycemia, creating protocols for inpatient hospital guidelines, identifying biomarkers to predict the development or progression of diabetic complications, detecting the earliest stages of complications to prevent progression of diseases, and developing sensitive diagnostic methods/treatment for those complications. Dr. Ang also serves as a Co-Director of Hospital Intensive Insulin Program. Dr. Ang has been actively involving in teaching internal medicine and podiatry residents, endocrinology fellows, and medical students in both ambulatory and inpatient clinical settings. She was a recipient of Goran Sundkvist Young Investigators Award for Clinical Science 2022. Dr. Ang is rated as an Experienced provider by MediFind in the treatment of Familial Hyperaldosteronism. Her top areas of expertise are Type 1 Diabetes (T1D), Diabetic Neuropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.

Merve Kutahyalioglu M.D., is a Clinical Assistant Professor in the Division of Metabolism, Endocrinology, and Diabetes. She completed her internal medicine internship and residency at the University of Texas Health Science Center, and endocrinology fellowship training at the Baylor College of Medicine. She is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism. Dr. Kutahyalioglu joined the faculty at the University of Michigan in 2021. She has an interest in general endocrinology. She is a part of the care team in the MEND Weight Management and MEND Post-Bariatric Surgery Care Program. Dr. Kutahyalioglu is rated as an Experienced provider by MediFind in the treatment of Familial Hyperaldosteronism. Her top areas of expertise are Malnutrition, Type 1 Diabetes (T1D), Obesity in Children, and Hyperparathyroidism.

Liselle Douyon is an Internal Medicine specialist and an Endocrinologist in Ann Arbor, Michigan. Dr. Douyon is rated as an Experienced provider by MediFind in the treatment of Familial Hyperaldosteronism. Her top areas of expertise are Postmenopausal Osteoporosis, Osteoporosis, Thyroid Nodule, and Juvenile Primary Osteoporosis.

Rachel Reinert is an Internal Medicine specialist and an Endocrinologist in Ann Arbor, Michigan. Dr. Reinert is rated as an Experienced provider by MediFind in the treatment of Familial Hyperaldosteronism. Her top areas of expertise are Type 1 Diabetes (T1D), Adrenal Insufficiency Pediatric, Familial Glucocorticoid Deficiency, and Glucocorticoid Resistance.

Eric Buras is an Internal Medicine specialist and an Endocrinologist in Ann Arbor, Michigan. Dr. Buras is rated as an Experienced provider by MediFind in the treatment of Familial Hyperaldosteronism. His top areas of expertise are Type 1 Diabetes (T1D), Neurohypophyseal Diabetes Insipidus, Panhypopituitarism, and Diabetes Insipidus (DI).

Jennifer Iyengar is an Internal Medicine specialist and an Endocrinologist in Ann Arbor, Michigan. Dr. Iyengar is rated as an Experienced provider by MediFind in the treatment of Familial Hyperaldosteronism. Her top areas of expertise are Type 1 Diabetes (T1D), Thyroid Nodule, Paget's Disease of Bone, and Type 2 Diabetes (T2D).

Nevin Ajluni, M.D., joined the team at the Division of Metabolism, Endocrinology & Diabetes (MEND) after serving a two-year endocrinology fellowship in the Division. She is a part of the care team in the MEND Weight Management Program, where she works with obese individuals by applying cutting-edge research findings and novel clinical strategies. She is an honors graduate of the Wayne State University School of Medicine and completed her internship and residency in internal medicine at the McGaw Medical Center of Northwestern University before coming to the University of Michigan. Dr. Ajluni is rated as an Experienced provider by MediFind in the treatment of Familial Hyperaldosteronism. Her top areas of expertise are Type 1 Diabetes (T1D), Familial Partial Lipodystrophy, Type 2 Diabetes (T2D), and Congenital Generalized Lipodystrophy.

Doctor Jennifer Wyckoff is a Clinical Professor of Internal Medicine in the Metabolism, Endocrinology and Diabetes/Podiatry Division. She received her MD degree from the University of South Florida in 1992 and completed her Internal Medicine Residency at the University of Utah in 1995. In addition, Dr. Wyckoff completed a fellowship in Endocrinology at the Brigham and Women's Hospital, Harvard Medical School, in 1999. Following that, she joined the faculty of the Joslin Diabetes Center, Harvard Medical School. While there, she practiced as part of the multidisciplinary Diabetes and Pregnancy program, a joint venture between the Joslin Diabetes Center and the Beth Israel Deaconess Hospital.In 2006, she joined the faculty at University of Michigan. Dr. Wyckoff serves as the Associate Clinical Chief for the Metabolism, Endocrinology and Diabetes/Podiatry Division and the Medical Director of the Adult Diabetes Education. Her clinical interests center on diabetes, with specific emphasis on diabetes and pregnancy, Type 1 diabetes and technology, patient education and cystic fibrosis related diabetes. Dr. Wyckoff is rated as an Experienced provider by MediFind in the treatment of Familial Hyperaldosteronism. Her top areas of expertise are Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Secondary Immunodeficiency (SID), and Gestational Diabetes.

Dr. Chun is a physician-scientist, who practices general endocrinology, including diabetes, thyroid diseases, and metabolic syndrome. His research is focused on the cellular and molecular mechanism of obesity, diabetes, and inflammatory and fibrotic tissue damages in endocrine disorders, such as Graves’ eye disease. Dr. Chun is rated as an Experienced provider by MediFind in the treatment of Familial Hyperaldosteronism. His top areas of expertise are Hyperparathyroidism, Neonatal Severe Hyperparathyroidism, Osteitis Fibrosa, and Familial Isolated Hyperparathyroidism.

Dr. Bodnar is the Assistant Chief of Endocrinology & Metabolism at Ann Arbor VA Health System. He is a graduate of the University of Michigan Medical School, and completed Internal Medicine Residency and Chief Residency, as well as his Fellowship in Endocrinology at Michigan Medicine. From 2014-2021 he was in private practice at Ann Arbor Endocrinology & Diabetes and was a Key Clinical Faculty Member in the St. Joseph Mercy Ann Arbor Internal Medicine Residency. Dr. Bodnar is rated as an Experienced provider by MediFind in the treatment of Familial Hyperaldosteronism. His top areas of expertise are Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Osteoporosis, and Pituitary Tumor.